Thus, IL-6, TNF-α and IFN-γ might represent important biomarkers for targeted treatments in schizophrenia and depression might represent an inflammatory endophenotype of schizophrenia with potential responsiveness to immune-based therapies. This evidence concerns the gene IFNG and schizophrenia.